Michael T. Scherzer

Chloroquine Sensitizes <i>GNAQ/11</i> -mutated Melanoma to MEK1/2 Inhibition

Amanda Truong, Jae Hyuk Yoo, Michael T. Scherzer et al. · Clinical Cancer Research · 2020 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

The PIM family of oncoproteins: Small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets

Kumar Saurabh, Michael T. Scherzer, Parag P. Shah et al. · Oncotarget · 2014 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +16

Fibroblast-Derived Extracellular Matrices: An Alternative Cell Culture System That Increases Metastatic Cellular Properties

Michael T. Scherzer, Sabine Waigel, Howard Donninger et al. · PLoS ONE · 2015 · 43 citations · Full text

Medicine, Cell Biology, Oncology +17

Suramin protects from cisplatin-induced acute kidney injury

Tess V. Dupre, Mark A. Doll, Parag P. Shah et al. · American Journal of Physiology-Renal Physiology · 2015 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer

Aria Vaishnavi, Michael T. Scherzer, Conan G. Kinsey et al. · Cell Reports · 2020 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17